Shelley K Ballentine from 1985 Armstrong Dr, Lansdale, PA 19446, age 49, Phone: 215 616-0461

Us Patents

Thiophene Amidines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions
view source
US Patent:

7138530, Nov 21, 2006
Filed:

May 28, 2003
Appl. No.:

10/515554
Inventors:

Nalin Subasinghe - West Chester PA, US
Ehab Khalil - West Chester PA, US
Kristi A. Leonard - West Chester PA, US
Farah Ali - Exton PA, US
Heather Hufnagel - Glenmoore PA, US
Jeremy M. Travins - Newtown Square PA, US
Shelley K. Ballentine - Lansdale PA, US
Kenneth T. Wilson - Media PA, US
Maxwell D. Cummings - Wayne PA, US
Wenxi Pan - Glenmoore PA, US
Joan Gushue - Collegeville PA, US
Sanath Meegalla - Boothwyn PA, US
Mark Wall - Harleysville PA, US
Jinsheng Chen - Exton PA, US
Jonathan M. Rudolph - Doylestown PA, US
Hui Huang - Belle Meade NJ, US
Assignee:

3-Dimensional Pharmaceuticals, Inc. - Yardley PA
International Classification:

C07D 333/32
A61K 31/38
US Classification:

549 65, 514445
Abstract:

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R, R, R, Rand Rare defined in the specification, Z is SO or SO, and Ar is an aromatic or heteroaromatic group as defined herein.

Thiophene Sulfoximines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions
view source
US Patent:

7385066, Jun 10, 2008
Filed:

Mar 14, 2006
Appl. No.:

11/375503
Inventors:

Nalin L. Subasinghe - Exton PA, US
Shelley Ballentine - Lansdale PA, US
Jeremy M. Travins - Downingtown PA, US
Ehab M. Khalil - West Chester PA, US
Farah Ali - Exton PA, US
Kristi A. Leonard - West Chester PA, US
Joan M. Gushue - Harleysville PA, US
Michael Peter Winters - Morgantown PA, US
Heather Hufnagel - Glenmoore PA, US
Maxwell David Cummings - Strafford PA, US
Assignee:

Janssen Pharmaceutica N.V. - Beerse
International Classification:

C07D 333/34
US Classification:

549 66
Abstract:

Disclosed are compounds for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade. The compounds are of Formula I.

Conjugated Complement Cascade Inhibitors
view source
US Patent:

7482376, Jan 27, 2009
Filed:

Jun 16, 2004
Appl. No.:

10/869430
Inventors:

Nalin Subasinghe - West Chester PA, US
Ehab Khalil - West Chester PA, US
Farah Ali - Exton PA, US
Heather Rae Hufnagel - Glenmoore PA, US
Shelley Ballentine - Lansdale PA, US
Jeremy M. Travins - Newtown Square PA, US
Kristi A. Leonard - West Chester PA, US
Roger F. Bone - Bridgewater NJ, US
Assignee:

3-Dimensional Pharmaceuticals, Inc. - Exton PA
International Classification:

A61K 31/381
C07D 333/10
US Classification:

514445, 549 29, 549 59, 549 62, 549 65, 514438, 514444
Abstract:

The present invention is directed to conjugated complement cascade inhibitors, and a method of treating a patient using a conjugated complement cascade inhibitor.

Inhibitors Of C-Fms Kinase
view source
US Patent:

7645755, Jan 12, 2010
Filed:

Apr 20, 2006
Appl. No.:

11/408096
Inventors:

Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath K. Meegalla - Boothwyn PA, US
M. Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - Media PA, US
Renee L. Desjarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:

Janssen Pharmaceutical N.V. - Beerse
International Classification:

A61K 31/5377
A61K 31/454
C07D 413/14
C07D 401/02
US Classification:

5142358, 514326, 544129, 546210
Abstract:

The invention is directed to compounds of Formula I:.

Inhibitors Of C-Fms Kinase
view source
US Patent:

7662837, Feb 16, 2010
Filed:

Oct 20, 2005
Appl. No.:

11/254276
Inventors:

Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath K. Meegalla - Boothwyn PA, US
M. Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - Media PA, US
Renee L. Desjarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:

Janssen Pharmaceutica N.V.
International Classification:

A61K 31/454
C07D 401/02
US Classification:

514326, 546210
Abstract:

The invention is directed to compounds of Formula I:.

Class Of Arylamide Compounds Useful As Inhibitors Of C-Fms Kinase
view source
US Patent:

7705042, Apr 27, 2010
Filed:

Oct 20, 2005
Appl. No.:

11/255043
Inventors:

Carl R. Illig - Phoenixville PA, US
Shelley K. Ballentine - Lansdale PA, US
Jinsheng Chen - Exton PA, US
Sanath Meegalla - Boothwyn PA, US
Jonathan Rudolph - Doylestown PA, US
Mark J. Wall - Harleysville PA, US
Kenneth J. Wilson - West Grove PA, US
Renee DesJarlais - Saint Davids PA, US
Carl L. Manthey - Downingtown PA, US
Christopher M. Flores - Lansdale PA, US
Christopher J. Molloy - Yardley PA, US
Assignee:

Janssen Pharmaceutica NV
International Classification:

A61K 31/34
US Classification:

514461, 544 56, 544 60, 544106, 544359, 546207, 5462681, 5483415, 548564, 549505
Abstract:

The invention relates to arylamide and hetereoarylamide compounds of Formula I:.

Method Of Inhibiting Flt3 Kinase
view source
US Patent:

7795279, Sep 14, 2010
Filed:

Oct 17, 2006
Appl. No.:

11/550077
Inventors:

Shelley K. Ballentine - Lansdale PA, US
Christian Andrew Baumann - Exton PA, US
Jinsheng Chen - Exton PA, US
Carl R. Illig - Phoenixville PA, US
Sanath K. Meegalla - Boothwyn PA, US
M. Jonathan Rudolph - Doylestown PA, US
Robert W. Tuman - Chalfont PA, US
Mark J. Wall - Flourtown PA, US
Kenneth Wilson - Media PA, US
Dana L. Johnson - Upper Black Eddy PA, US
Assignee:

Janssen Pharmaceutica NV - Beerse
International Classification:

A61K 31/445
C07D 293/10
US Classification:

514326, 514908, 544 1
Abstract:

A method of reducing or inhibiting kinase activity of FLT3 in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 using a compound of the present invention:.

Thiophene Sulfoximines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions
view source
US Patent:

7868023, Jan 11, 2011
Filed:

Apr 3, 2008
Appl. No.:

12/061873
Inventors:

Nalin L. Subasinghe - Exton PA, US
Shelley Ballentine - Lansdale PA, US
Jeremy M. Travins - Downingtown PA, US
Ehab M. Khalil - West Chester PA, US
Farah Ali - Exton PA, US
Kristi A. Leonard - West Chester PA, US
Joan M. Gushue - Harleysville PA, US
Michael Peter Winters - Morgantown PA, US
Heather Hufnagel - Glenmoore PA, US
Maxwell David Cummings - Strafford PA, US
Assignee:

Janssen Pharmaceutica NV
International Classification:

A61K 31/381
A61K 31/44
C07D 409/12
US Classification:

514334, 514444, 5462804, 549 59
Abstract:

Disclosed are compounds for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade. The compounds are of Formula I.

Shelley K Ballentine

Shelley Ballentine Phones & Addresses

Us Patents

Thiophene Amidines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions

Thiophene Sulfoximines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions

Conjugated Complement Cascade Inhibitors

Inhibitors Of C-Fms Kinase

Inhibitors Of C-Fms Kinase

Class Of Arylamide Compounds Useful As Inhibitors Of C-Fms Kinase

Method Of Inhibiting Flt3 Kinase

Thiophene Sulfoximines, Compositions Thereof, And Methods Of Treating Complement-Mediated Diseases And Conditions

Myspace

Shelley Ballentine (Shell...

Shelley Ballentine

Facebook

Shelley Lilbaby Ballentine

Youtube

koc4 gaby ballentine vs laila